Parvati Sweetners board approves unaudited standalone financial results for Q2FY27 and half-year period
BSE India
Parvati Sweetners board approves the standalone unaudited financial results and limited review report for the quarter and half-year ended September 30, 2026. The approval includes the standalone unaudited statement of assets and liabilities and the statement of cash flow for the same period. The filing serves as a formal notification of the board meeting outcome held on November 14, 2026.
Sep 2026Jun 2026Sep 2025QoQ%YoY%
Revenue/Sales 13.73 35.73 0.16 -61.56% 8570.08%
EBITDA -0.36 1.61 -1.74 -122.63% 79.10%
Op. profit margin(%) -3.18 4.30 -1150.44 -173.88% 99.72%
Net Profit -2.03 0.32 -3.33 -740.33% 39.06%
EPS -0.14 0.02 -0.22 -800.00% 36.36%
* Standalone data
662.35
-0.30%
Jindal Poly Films board approves Q2FY27 unaudited financial results with qualified audit opinion
BSE India
Jindal Poly Films board approves the unaudited standalone and consolidated financial results for Q2FY27 and H1FY27 ended September 30, 2026. The statutory auditors issue a modified qualified opinion on the consolidated financial results for the period. The company provides these results in compliance with SEBI Listing Obligations and Disclosure Requirements. No specific financial metrics are disclosed in this procedural filing.
Sep 2026Jun 2026Sep 2025QoQ%YoY%
Revenue/Sales 738.07 695.80 410.39 6.07% 79.84%
EBITDA -8.20 179.66 61.18 -104.57% -113.41%
Op. profit margin(%) -5.78 1.42 2.73 -506.88% -311.56%
Net Profit -84.91 108.00 -13.41 -178.61% -533.22%
EPS -19.45 24.48 -2.92 -179.45% -566.10%
* Consolidated data
1684.00
-0.54%
Kernex Microsystems board approves unaudited Q2FY27 financial results and grants 25,000 ESOPs
BSE India
Kernex Microsystems board approves the unaudited standalone and consolidated financial results for the quarter and half-year ended September 2026. The board also approves the grant of 25,000 ESOPs to eligible employees. The meeting includes the formal adoption of the statement of assets and liabilities as of September 30, 2026. No specific financial figures or segmental drivers are provided in the announcement.
Sep 2026Jun 2026Sep 2025QoQ%YoY%
Revenue/Sales 542.63 503.58 47.12 7.75% 1051.67%
EBITDA 192.05 163.31 14.76 17.60% 1201.15%
Op. profit margin(%) 35.25 32.33 30.29 9.03% 16.39%
Net Profit 129.01 109.85 6.57 17.45% 1862.37%
EPS 76.77 65.37 3.87 17.44% 1883.72%
* Consolidated data
352.05
-1.26%
Panacea Biotec approves unaudited standalone and consolidated financial results for Q2FY27 and H1FY27
BSE India
Panacea Biotec's board approves the unaudited financial results for the quarter and half-year ended September 30, 2026. The financial statements underwent a limited review by statutory auditors and were reviewed by the Audit Committee. The announcement includes the provisional results for both standalone and consolidated entities. The company provides the official results and limited review report for investor access.
Sep 2026Jun 2026Sep 2025QoQ%YoY%
Revenue/Sales 189.67 199.57 141.13 -4.96% 34.39%
EBITDA 24.87 12.65 -8.69 96.60% 386.19%
Op. profit margin(%) 8.17 2.84 -12.61 187.64% 164.83%
Net Profit 11.61 2.30 -13.92 404.78% 183.41%
EPS 1.90 0.38 -2.27 400.00% 183.70%
* Consolidated data
26.21
0.46%
Vishnu Prakash R Punglia approves unaudited financial results for Q2FY27 and H1FY27
BSE India
Vishnu Prakash R Punglia board approves the unaudited financial results for the quarter and half-year ended September 30, 2026. The board also takes on record the limited review report from statutory auditors M/s Banshi Jain & Associates. The announcement confirms the completion of the audit committee review and the formal adoption of the financial statements. No specific revenue or profit figures are disclosed in this procedural filing.
Sep 2026Jun 2026Sep 2025QoQ%YoY%
Revenue/Sales 168.49 137.88 295.68 22.20% -43.02%
EBITDA -13.29 -32.46 26.56 59.06% -150.03%
Op. profit margin(%) 5.75 -24.67 8.23 123.30% -30.17%
Net Profit -25.29 -39.32 3.65 35.66% -792.99%
EPS -2.03 -3.15 0.29 35.56% -800.00%
* Standalone data
3.28
0.31%
Dhenu Buildcon Infra board approves unaudited financial results for Q2FY27 and H1FY27
BSE India
Dhenu Buildcon Infra board of directors approves the unaudited financial results for the quarter and half year ended September 30, 2026. The announcement includes the Limited Review Report issued by the statutory auditors. The filing confirms the completion of the financial review for the period without disclosing specific numerical performance metrics in the notice.
Sep 2026Jun 2026Sep 2025QoQ%YoY%
Revenue/Sales 0.09 1.19 0.52 -92.24% -82.10%
EBITDA 0.01 1.14 0.25 -99.51% -97.72%
Op. profit margin(%) 6.06 95.81 47.59 -93.67% -87.26%
Net Profit -0.04 0.84 0.24 -104.39% -115.24%
EPS 0.00 0.00 0.13 -100.00% -100.00%
* Standalone data
144.00
1.41%
Gallard Steel approves unaudited standalone and consolidated financial results for H1FY27
BSE India
Gallard Steel's board of directors approves the unaudited standalone and consolidated financial results for the half-year ended September 30, 2026. The announcement includes the statement of assets and liabilities, cash flow statement, and the statutory auditors' limited review report. The filing serves as a formal regulatory submission under SEBI (LODR) Regulations, 33(3). No specific financial figures or performance drivers are disclosed in this procedural filing.
Parvati Sweetners board approves standalone unaudited financial results for Q2FY27 and H1FY27
BSE India
Parvati Sweetners board of directors meets to approve the standalone unaudited financial results for the quarter and half year ended September 30, 2026. The board takes on record the limited review report from the statutory auditors. The meeting also includes approval of the standalone unaudited statement of assets and liabilities and the statement of cash flows for H1FY27.
Sep 2026Jun 2026Sep 2025QoQ%YoY%
Revenue/Sales 13.73 35.73 0.16 -61.56% 8570.08%
EBITDA -0.36 1.61 -1.74 -122.63% 79.10%
Op. profit margin(%) -3.18 4.30 -1150.44 -173.88% 99.72%
Net Profit -2.03 0.32 -3.33 -740.33% 39.06%
EPS -0.14 0.02 -0.22 -800.00% 36.36%
* Standalone data
5.29
-1.12%
Sep 2026Jun 2026Sep 2025QoQ%YoY%
Revenue/Sales 13.89 11.97 12.40 16.06% 12.05%
EBITDA 1.32 2.08 0.98 -36.71% 35.04%
Op. profit margin(%) 1.42 5.94 5.67 -76.04% -74.92%
Net Profit 0.39 0.92 0.96 -57.78% -59.28%
EPS 0.01 0.03 0.03 -66.67% -68.15%
* Consolidated data
46.00
-4.56%
SSMD Agrotech approves unaudited standalone financial results for the half-year ended 30th September 2026
BSE India
SSMD Agrotech approves its unaudited standalone financial results for the half-year ended 30th September 2026, accompanied by a Limited Review Report from the Statutory Auditor. The board notes that the Monitoring Agency Report regarding the utilization of IPO proceeds for the quarter ended 31st March 2026 is currently pending receipt. No specific financial figures or segmental performance metrics are disclosed in this administrative filing.